Our results indicate that Serpine2 is a regulatory gene capable of inducing HC regeneration from Lgr5+ progenitors in the mouse cochlea, suggesting a new line of study for the future clinical therapy of SNHL. The gene discussed is LGR5; the disease is sensorineural hearing loss disorder.